R&D in Healthcare
Vibrant science across the globe
Patients are at the center of all our research and development efforts. We are committed to innovation in science that will ultimately make a meaningful difference in people’s lives all over the world. Ever since Merck KGaA, Darmstadt, Germany, was founded 350 years ago, we have gained unmatched experience in the discovery, development and manufacturing of medicines.
On top of leveraging our experience and expertise, we also believe that a healthier future deserves a sizable investment. In 2018 our Healthcare business devoted roughly 20% of total sales to R&D activities aimed at discovering and developing new therapies. All of these are integrated in a global organization with four strategically located and highly connected hubs on three continents: Darmstadt, Boston, Beijing and Tokyo.
Latest R&D NewsView All News
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations.
Merck KGaA, Darmstadt, Germany, today announced the latest research representing the Company’s innovative oncology portfolio has been accepted for presentation at this year’s ASCO.
This year’s winner of the Heinrich Emanuel Merck Award for Analytical Science obtained a PhD in Chemical Sciences in 2002 at the University of Liège, Belgium.